BAYZED HEALTH (02609) Cash Flow Statement

5.030
-0.110-2.14%

Not Open May 21 16:07 CST

6.63BMarket Cap-457.27P/E (TTM)

BAYZED HEALTH (02609) Cash Flow

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Cash flow from operating activities

Earning before tax

-30.20%9.29M

----

388.76%13.31M

----

92.63%-4.61M

---4.74M

-14.02%-62.52M

---54.84M

Profit adjustment

Impairment and provisions:

-26.19%479K

----

136.86%649K

----

-86.72%274K

--200K

347.51%2.06M

--461K

-Impairment of trade receivables (reversal)

-26.19%479K

----

136.86%649K

----

-86.72%274K

--200K

347.51%2.06M

--461K

Asset sale loss (gain):

450.00%7K

----

-101.12%-2K

----

306.82%179K

--167K

113.17%44K

---334K

-Loss (gain) on sale of property, machinery and equipment

450.00%7K

----

-101.12%-2K

----

306.82%179K

--167K

113.17%44K

---334K

Depreciation and amortization:

4.03%90.92M

----

1.30%87.4M

----

15.73%86.27M

--42.04M

48.10%74.54M

--50.33M

-Depreciation

4.03%90.92M

----

1.30%87.4M

----

15.73%86.27M

--42.04M

48.10%74.54M

--50.33M

Financial expense

-0.45%21.58M

----

-19.84%21.68M

----

10.66%27.04M

--13.73M

16.05%24.44M

--21.06M

Special items

----

0.00%-2.56M

---2.56M

Operating profit before the change of operating capital

-0.62%122.27M

----

12.71%123.03M

----

203.20%109.16M

--51.39M

154.98%36M

--14.12M

Change of operating capital

Inventory (increase) decrease

193.29%2.89M

----

17.60%-3.1M

----

48.77%-3.76M

---7.39M

44.34%-7.34M

---13.19M

Accounts receivable (increase)decrease

120.81%17.98M

----

-228.94%-86.42M

----

20.59%-26.27M

--7.97M

-12.58%-33.08M

---29.39M

Accounts payable increase (decrease)

-57.22%98.41M

----

214.99%230.05M

----

15.14%73.04M

--27.64M

59.00%63.43M

--39.89M

prepayments (increase)decrease

270.37%7.88M

----

-215.25%-4.62M

----

180.85%4.01M

---1.69M

6.90%-4.96M

---5.33M

Special items for working capital changes

86.51%-8.52M

----

-709.44%-63.11M

----

-111.25%-7.8M

--19.25M

682.66%69.33M

--8.86M

Cash from business operations

23.02%240.92M

9.34%99.19M

31.99%195.84M

-6.66%90.72M

20.26%148.38M

--97.19M

724.47%123.37M

--14.96M

Other taxs

31.93%-18.58M

30.90%-10.01M

-36.45%-27.3M

15.39%-14.48M

-122.79%-20M

---17.12M

-5.03%-8.98M

---8.55M

Net cash from operations

31.92%222.34M

16.98%89.18M

31.29%168.54M

-4.79%76.23M

12.22%128.37M

--80.07M

1,683.24%114.4M

--6.42M

Cash flow from investment activities

Loan receivable (increase) decrease

-230.63%-128.83M

----

1,691.16%98.62M

----

81.95%-6.2M

----

58.40%-34.34M

---82.53M

Purchase of fixed assets

23.78%-33.44M

9.26%-20.34M

3.29%-43.87M

6.41%-22.42M

-54.12%-45.37M

---23.95M

40.00%-29.44M

---49.06M

Purchase of intangible assets

-73.22%-4.47M

-21.14%-298K

69.43%-2.58M

82.89%-246K

-22.09%-8.44M

---1.44M

-40.65%-6.91M

---4.92M

Acquisition of subsidiaries

----

-527.55%-149.36M

---23.8M

Other items in the investment business

----

-94.29%4.4M

----

479.05%77.05M

-87.68%1.4M

--13.31M

194.50%11.36M

--3.86M

Net cash from investment operations

-419.63%-166.74M

-129.85%-16.24M

189.01%52.17M

550.27%54.39M

71.92%-58.61M

---12.08M

-33.39%-208.68M

---156.45M

Net cash before financing

-74.81%55.61M

-44.16%72.94M

216.36%220.71M

92.13%130.63M

173.99%69.77M

--67.99M

37.16%-94.29M

---150.03M

Cash flow from financing activities

New borrowing

29.44%265.74M

40.21%150.4M

-15.71%205.31M

-6.71%107.26M

27.18%243.59M

--114.98M

171.28%191.53M

--70.6M

Refund

-22.39%-429.4M

-14.39%-159.02M

-31.55%-350.85M

-3.96%-139.02M

-75.82%-266.71M

---133.72M

0.29%-151.69M

---152.13M

Issuing shares

--513.13M

----

261.89%128.54M

--22.54M

-90.88%35.52M

--389.49M

Interest paid - financing

-0.14%-21.53M

9.34%-10.51M

19.34%-21.5M

14.07%-11.59M

-12.87%-26.66M

---13.49M

-12.74%-23.62M

---20.95M

Dividends paid - financing

----

---9.18M

----

Issuance expenses and redemption of securities expenses

-553.19%-18.73M

-647.84%-17.15M

-57.35%-2.87M

-163.26%-2.29M

-186.93%-1.82M

---871K

---635K

----

Other items of the financing business

-184.34%-17.25M

----

781.21%20.45M

28.65%-3.79M

-123.39%-3M

---5.31M

167.98%12.83M

---18.88M

Net cash from financing operations

258.94%267.74M

947.50%468.03M

-458.13%-168.46M

-61.34%-55.23M

-11.96%47.04M

---34.23M

-76.81%53.43M

--230.36M

Effect of rate

---1.61M

----

Net Cash

518.85%323.34M

617.47%540.97M

-55.27%52.25M

123.35%75.4M

385.86%116.8M

--33.76M

-150.87%-40.86M

--80.32M

Begining period cash

21.59%294.24M

93.30%241.99M

-24.61%125.19M

--125.19M

93.70%166.05M

--85.73M

Cash at the end

109.34%615.97M

163.15%835.21M

21.59%294.24M

99.68%317.39M

93.30%241.99M

--158.95M

-24.61%125.19M

--166.05M

Cash balance analysis

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

KPMG

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Cash flow from operating activities
Earning before tax	-30.20%9.29M	----	388.76%13.31M	----	92.63%-4.61M	---4.74M	-14.02%-62.52M	---54.84M
Profit adjustment
Impairment and provisions:	-26.19%479K	----	136.86%649K	----	-86.72%274K	--200K	347.51%2.06M	--461K
-Impairment of trade receivables (reversal)	-26.19%479K	----	136.86%649K	----	-86.72%274K	--200K	347.51%2.06M	--461K
Asset sale loss (gain):	450.00%7K	----	-101.12%-2K	----	306.82%179K	--167K	113.17%44K	---334K
-Loss (gain) on sale of property, machinery and equipment	450.00%7K	----	-101.12%-2K	----	306.82%179K	--167K	113.17%44K	---334K
Depreciation and amortization:	4.03%90.92M	----	1.30%87.4M	----	15.73%86.27M	--42.04M	48.10%74.54M	--50.33M
-Depreciation	4.03%90.92M	----	1.30%87.4M	----	15.73%86.27M	--42.04M	48.10%74.54M	--50.33M
Financial expense	-0.45%21.58M	----	-19.84%21.68M	----	10.66%27.04M	--13.73M	16.05%24.44M	--21.06M
Special items	----	----	----	----	----	----	0.00%-2.56M	---2.56M
Operating profit before the change of operating capital	-0.62%122.27M	----	12.71%123.03M	----	203.20%109.16M	--51.39M	154.98%36M	--14.12M
Change of operating capital
Inventory (increase) decrease	193.29%2.89M	----	17.60%-3.1M	----	48.77%-3.76M	---7.39M	44.34%-7.34M	---13.19M
Accounts receivable (increase)decrease	120.81%17.98M	----	-228.94%-86.42M	----	20.59%-26.27M	--7.97M	-12.58%-33.08M	---29.39M
Accounts payable increase (decrease)	-57.22%98.41M	----	214.99%230.05M	----	15.14%73.04M	--27.64M	59.00%63.43M	--39.89M
prepayments (increase)decrease	270.37%7.88M	----	-215.25%-4.62M	----	180.85%4.01M	---1.69M	6.90%-4.96M	---5.33M
Special items for working capital changes	86.51%-8.52M	----	-709.44%-63.11M	----	-111.25%-7.8M	--19.25M	682.66%69.33M	--8.86M
Cash from business operations	23.02%240.92M	9.34%99.19M	31.99%195.84M	-6.66%90.72M	20.26%148.38M	--97.19M	724.47%123.37M	--14.96M
Other taxs	31.93%-18.58M	30.90%-10.01M	-36.45%-27.3M	15.39%-14.48M	-122.79%-20M	---17.12M	-5.03%-8.98M	---8.55M
Net cash from operations	31.92%222.34M	16.98%89.18M	31.29%168.54M	-4.79%76.23M	12.22%128.37M	--80.07M	1,683.24%114.4M	--6.42M
Cash flow from investment activities
Loan receivable (increase) decrease	-230.63%-128.83M	----	1,691.16%98.62M	----	81.95%-6.2M	----	58.40%-34.34M	---82.53M
Purchase of fixed assets	23.78%-33.44M	9.26%-20.34M	3.29%-43.87M	6.41%-22.42M	-54.12%-45.37M	---23.95M	40.00%-29.44M	---49.06M
Purchase of intangible assets	-73.22%-4.47M	-21.14%-298K	69.43%-2.58M	82.89%-246K	-22.09%-8.44M	---1.44M	-40.65%-6.91M	---4.92M
Acquisition of subsidiaries	----	----	----	----	----	----	-527.55%-149.36M	---23.8M
Other items in the investment business	----	-94.29%4.4M	----	479.05%77.05M	-87.68%1.4M	--13.31M	194.50%11.36M	--3.86M
Net cash from investment operations	-419.63%-166.74M	-129.85%-16.24M	189.01%52.17M	550.27%54.39M	71.92%-58.61M	---12.08M	-33.39%-208.68M	---156.45M
Net cash before financing	-74.81%55.61M	-44.16%72.94M	216.36%220.71M	92.13%130.63M	173.99%69.77M	--67.99M	37.16%-94.29M	---150.03M
Cash flow from financing activities
New borrowing	29.44%265.74M	40.21%150.4M	-15.71%205.31M	-6.71%107.26M	27.18%243.59M	--114.98M	171.28%191.53M	--70.6M
Refund	-22.39%-429.4M	-14.39%-159.02M	-31.55%-350.85M	-3.96%-139.02M	-75.82%-266.71M	---133.72M	0.29%-151.69M	---152.13M
Issuing shares	--513.13M	--513.13M	----	----	261.89%128.54M	--22.54M	-90.88%35.52M	--389.49M
Interest paid - financing	-0.14%-21.53M	9.34%-10.51M	19.34%-21.5M	14.07%-11.59M	-12.87%-26.66M	---13.49M	-12.74%-23.62M	---20.95M
Dividends paid - financing	----	----	----	----	---9.18M	---9.18M	----	----
Issuance expenses and redemption of securities expenses	-553.19%-18.73M	-647.84%-17.15M	-57.35%-2.87M	-163.26%-2.29M	-186.93%-1.82M	---871K	---635K	----
Other items of the financing business	-184.34%-17.25M	----	781.21%20.45M	28.65%-3.79M	-123.39%-3M	---5.31M	167.98%12.83M	---18.88M
Net cash from financing operations	258.94%267.74M	947.50%468.03M	-458.13%-168.46M	-61.34%-55.23M	-11.96%47.04M	---34.23M	-76.81%53.43M	--230.36M
Effect of rate	---1.61M	----	----	----	----	----	----	----
Net Cash	518.85%323.34M	617.47%540.97M	-55.27%52.25M	123.35%75.4M	385.86%116.8M	--33.76M	-150.87%-40.86M	--80.32M
Begining period cash	21.59%294.24M	21.59%294.24M	93.30%241.99M	93.30%241.99M	-24.61%125.19M	--125.19M	93.70%166.05M	--85.73M
Cash at the end	109.34%615.97M	163.15%835.21M	21.59%294.24M	99.68%317.39M	93.30%241.99M	--158.95M	-24.61%125.19M	--166.05M
Cash balance analysis
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion
Auditor	KPMG	--	KPMG	--	KPMG	--	KPMG	KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"